Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Long-term anti-cancer implants inhibiting the activity of tumor growth in animal models].

Yu M, Du Z, Xue J, Guo H, Wang R, Xiong W, Li C.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):552-5. Chinese.

PMID:
23865317
2.

[The study of absorbable sustained-release implants and animal experiments to prevent recurrence of bladder cancer].

Yu M, Du Z, Xue J, Wang K.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Apr;28(2):322-5. Chinese.

PMID:
21604495
3.

Intravesical single and combination therapy in superficial bladder cancer. An experimental study.

Rübben H, Dahm HH, von Uelft W, Rüttgers L, Friedrichs R, Lutzeyer W.

Eur Urol. 1982;8(5):284-90.

PMID:
7117342
4.

[Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents].

Hirao Y, Momose H, Samma S, Ozono S, Babaya K, Okajima E.

Hinyokika Kiyo. 1988 Nov;34(11):1885-93. Japanese.

5.

[Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].

Masuda H, Hirai M, Ohtawara Y, Tajima A, Aso Y.

Nihon Hinyokika Gakkai Zasshi. 1990 Apr;81(4):577-82. Japanese.

6.

Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S, Ozono S, Hirao Y, Okajima E.

Urol Res. 1987;15(6):329-34.

PMID:
3433593
7.

Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.

Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K.

Cancer Res. 2000 Oct 15;60(20):5599-602.

9.

In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer.

Chen G, He Y, Wu X, Zhang Y, Luo C, Jing P.

Braz J Med Biol Res. 2012 Aug;45(8):771-6. Epub 2012 Jul 12.

10.

[Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].

Li Q, Xu T, Wang XF.

Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):904-7. Chinese.

PMID:
20193328
11.

[Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].

Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y.

Gan To Kagaku Ryoho. 1982 Mar;9(3):473-9. Japanese.

PMID:
6820898
13.

Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.

Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ, Wang CJ.

J Ethnopharmacol. 2011 Apr 26;135(1):162-72. doi: 10.1016/j.jep.2011.03.011. Epub 2011 Mar 17.

PMID:
21396995
14.

Double short-time exposure to pirarubicin produces higher cytotoxicity against T24 bladder cancer cells.

Maruyama T, Higuchi Y, Suzuki T, Qiu J, Yamamoto S, Shima H.

J Infect Chemother. 2011 Feb;17(1):11-6. doi: 10.1007/s10156-010-0088-y. Epub 2010 Jul 15.

PMID:
20632198
15.
16.
17.

[Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].

Kobayashi M, Sugaya Y, Yuzawa M, Ochi M, Morita T, Kobayashi Y, Tokue A, Hara Y.

Gan To Kagaku Ryoho. 1998 Sep;25(11):1771-4. Japanese.

PMID:
9757205
18.
19.

[Effect of liarozole on the cell proliferation activity in the rat urinary bladder epithelium induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].

Nagae H, Otawara Y, Suzuki K, Fujita K.

Nihon Hinyokika Gakkai Zasshi. 1999 Oct;90(10):838-42. Japanese.

20.

[A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].

Kawamura J, Tochigi H, Obata K, Ueda K, Otaguro K, Kuriyama M, Shinoda M, Naruse K, Murase T, Hasegawa Y.

Hinyokika Kiyo. 1992 Mar;38(3):379-85. Japanese.

Supplemental Content

Support Center